Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluoride varnish + tricalcium phosphate (brand name: Clinpro White Varnish) is a topical dental remineralizing agent developed by 3M. It combines 5% sodium fluoride (NaF) with a functionalized tricalcium phosphate (fTCP) component. The formulation is designed to provide a sustained release of fluoride, calcium, and phosphate ions directly to the tooth surface. Its primary mechanism of action involves the promotion of enamel remineralization by facilitating the formation of fluorapatite and inhibiting the demineralization of the hydroxyapatite mineral structure. It is indicated for the prevention and treatment of dental caries, enamel white spot lesions (WSLs), and tooth demineralization, particularly in high-risk populations such as patients undergoing fixed orthodontic treatment. The University of Hong Kong has conducted Phase 2 clinical trials evaluating its efficacy in preventing white spot lesions during orthodontic therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride + tricalcium phosphate (3M).